id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-1149-0027,FDA,FDA-2021-D-1149,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; Emergency Use Authorization of Medical Products and Related Authorities",Notice,30 Day Proposed Information Collection,2023-07-12T04:00:00Z,2023,7,2023-07-12T04:00:00Z,2023-08-12T03:59:59Z,2023-07-17T19:56:49Z,2023-14714,0,0,0900006485c8be44
FDA-2021-D-1149-0026,FDA,FDA-2021-D-1149,"Transition Plan for Medical Devices Issued Emergency Use Authorizations Related to Coronavirus Disease 2019 (COVID–19); Guidance for Industry, Other Stakeholders, and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2023-03-27T04:00:00Z,2023,3,,,2023-03-27T15:51:25Z,2023-06292,0,0,0900006485869a25
FDA-2021-D-1149-0025,FDA,FDA-2021-D-1149,"Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) Related to Coronavirus Disease 2019 (COVID-19) Guidance for Industry, Other Stakeholders, and Food and Drug Administration Staff",Other,Guidance,2023-03-24T04:00:00Z,2023,3,2023-03-24T04:00:00Z,,2025-11-14T10:00:23Z,,1,0,090000648584369d